Ascletis Pharma Inc (2VJ) — Net Asset Quality Index
Ascletis Pharma Inc (2VJ) has a Net Asset Quality Index of 93.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.07 Billion minus total liabilities of €132.26 Million yields net assets of €1.93 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 2VJ current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ascletis Pharma Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how Ascletis Pharma Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 93.6%, representing net assets of €1.93 Billion against total assets of €2.07 Billion EUR. For live market cap and overall valuation, see 2VJ company net worth.
Annual Net Asset Quality Index for Ascletis Pharma Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Ascletis Pharma Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Ascletis Pharma Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.6% | €1.93 Billion | €2.07 Billion | €132.26 Million | ▲ +1.1 pp |
| 2024 | 92.5% | €1.97 Billion | €2.12 Billion | €158.41 Million | ▼ -1.5 pp |
| 2023 | 94.0% | €2.34 Billion | €2.49 Billion | €148.94 Million | ▼ -1.6 pp |
| 2022 | 95.6% | €2.54 Billion | €2.66 Billion | €117.16 Million | ▼ -0.8 pp |
| 2021 | 96.4% | €2.73 Billion | €2.83 Billion | €100.89 Million | ▼ -0.8 pp |
| 2020 | 97.2% | €2.98 Billion | €3.07 Billion | €85.42 Million | ▲ +0.2 pp |
| 2019 | 97.0% | €3.32 Billion | €3.43 Billion | €102.17 Million | ▼ -0.1 pp |
| 2018 | 97.2% | €3.43 Billion | €3.53 Billion | €100.19 Million | ▲ +9.4 pp |
| 2017 | 87.8% | €869.83 Million | €991.25 Million | €121.42 Million | ▲ +11.5 pp |
| 2016 | 76.3% | €409.08 Million | €536.26 Million | €127.18 Million | — |